Skip to main content
. 2016 Jan 21;7(15):19960–19974. doi: 10.18632/oncotarget.6963

Table 3. Expression of LncRNA and BDH2 in ESCC cases.

Parameter n LncRNA BDH2
Expression level P value Expression level P value
Gender
 Male 39 0.53±0.179 0.611 0.23±0.068 0.390
 Female 21 0.51±0.118 0.24±0.053
Age(years)
 <60 21 0.49±0.171 0.297 0.23±0.066 0.941
 ≥60 39 0.54±0.153 0.23±0.63
Location
 Low 13 0.43±0.183 0.022* 0.23±0.066 0.609
 Middle 47 0.54±0.145 0.24±0.062
Differentiation
 Well 17 0.50±0.181 0.760 0.24±0.071 0.799
 Moderate 32 0.52±0.135 0.23±0.060
 Poor 11 0.55±0.199 0.24±0.064
TNM stage
 I 17 0.43±0.095 0.017* 0.20±0.045 0.024*
 II 30 0.52±0.163 0.24±0.069
 III 13 0.57±0.181 0.26±0.061
Lymph node metastasis
 Negative 40 0.51±0.161 0.430 0.23±0.063 0.977
 Positive 20 0.54±0.158 0.23±0.065
*

Indicated statistical significance (P<0.05)